Some cancers may not require immediate treatment, from prostate cancer to thyroid tumors. Medical experts share when ...

One test could have prevented terminal prostate cancer, says patient - Research has shown that the use of the PSA test varies ...

Prostate cancer is one of the most common cancers among men, often developing slowly and sometimes remaining asymptomatic in its early stages. Dr. Johnson's experience underscores the significance of ...

The Alliance for Clinical Trials in Oncology has launched a randomized phase III clinical trial called RECIPROCAL (Alliance ...

An NHS patient waited over 400 days to start investigations for suspected prostate cancer. Another Scot waited 352 days with ...

Nonlinear improvement seen in relative benefit of distant metastasis, OS, with reduced benefits beyond nine to 12 months of ADT.

Advances in technology transforming the approach to prostate cancer: Dr Likhiteswer Pallagani: Shardul Nautiyal, Mumbai ...

Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.

The IAEA is launching a year-long coordinated research project to develop computed tomography-based guidelines on prostate cancer contouring — a critical step in the cancer treatment process that ...

The marathon surgical session, conducted between 8 am and 5 pm, was led by Dr (prof) Santosh Kumar, with the procedures ...

PYLCLARI® provides solutions to a wider patient group across Poland where there is high demand and unmet need PARIS, Dec. 23, ...